Philly Jury Urged To Find Takeda Cancer Warnings Fell Short
By Matt Fair ( October 2, 2014, 5:45 PM EDT) -- A Philadelphia jury was urged during closing arguments Thursday to find that Takeda Pharmaceutical Co. Ltd. had failed to provide adequate warnings to a plaintiff's physician about the risk of bladder cancer associated with the diabetes drug Actos....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.